TY - JOUR
T1 - Prognostic Understanding and Preference for the Communication Process with Physicians in Hospitalized Heart Failure Patients
AU - Kitakata, Hiroki
AU - Kono, Takashi
AU - Kohsaka, Shun
AU - Fujisawa, Daisuke
AU - Nakano, Naomi
AU - Shiraishi, Yasuyuki
AU - Katsumata, Yoshinori
AU - Yuasa, Shinsuke
AU - Fukuda, Keiichi
N1 - Funding Information:
Supported by a Grant-in-Aid for Young Scientists (JPSS KAKENHI, 18K15860), a Grant-in-Aid for Scientific Research (17K09526, 20K08408), Health Labour Sciences Research Grant (14528506), and Grant from the Japan Agency for Medical Research and Development (201439013C).
Funding Information:
Dr. Shiraishi is affiliated with an endowed department by Nippon Shinyaku Co., Ltd., and received a research grant from the SECOM Science and Technology Foundation and an honorarium from Otsuka Pharmaceutical Co., Ltd.
Funding Information:
Supported by a Grant-in-Aid for Young Scientists (JPSS KAKENHI, 18K15860), a Grant-in-Aid for Scientific Research (17K09526, 20K08408), Health Labour Sciences Research Grant (14528506), and Grant from the Japan Agency for Medical Research and Development (201439013C). Dr Kohsaka reports investigator-initiated grant funding from Bayer and Daiichi Sankyo. Dr. Shiraishi is affiliated with an endowed department by Nippon Shinyaku Co. Ltd. and received a research grant from the SECOM Science and Technology Foundation and an honorarium from Otsuka Pharmaceutical Co. Ltd.
Funding Information:
Dr Kohsaka reports investigator-initiated grant funding from Bayer and Daiichi Sankyo.
Publisher Copyright:
© 2020 Elsevier Inc.
PY - 2021/3
Y1 - 2021/3
N2 - Background: Heart failure (HF) is a highly prevalent, heterogeneous, and life-threatening condition. Precise prognostic understanding is essential for effective decision making, but little is known about patients’ attitudes toward prognostic communication with their physicians. Methods and Results: We conducted a questionnaire survey, consisting of patients’ prognostic understanding, preferences for information disclosure, and depressive symptoms, among hospitalized patients with HF (92 items in total). Individual 2-year survival rates were calculated using the Seattle Heart Failure Model, and its agreement level with patient self-expectations of 2-year survival were assessed. A total of 113 patients completed the survey (male 65.5%, median age 75.0 years, interquartile range 66.0–81.0 years). Compared with the Seattle Heart Failure Model prediction, patient expectation of 2-year survival was matched only in 27.8% of patients; their agreement level was low (weighted kappa = 0.11). Notably, 50.9% wished to know “more,” although 27.7% felt that they did not have an adequate prognostic discussion. Compared with the known prognostic variables (eg, age and HF severity), logistic regression analysis demonstrated that female and less depressive patients were associated with patients’ preference for “more” prognostic discussion. Conclusions: Patients’ overall prognostic understanding was suboptimal. The communication process requires further improvement for patients to accurately understand their HF prognosis and be involved in making a better informed decision.
AB - Background: Heart failure (HF) is a highly prevalent, heterogeneous, and life-threatening condition. Precise prognostic understanding is essential for effective decision making, but little is known about patients’ attitudes toward prognostic communication with their physicians. Methods and Results: We conducted a questionnaire survey, consisting of patients’ prognostic understanding, preferences for information disclosure, and depressive symptoms, among hospitalized patients with HF (92 items in total). Individual 2-year survival rates were calculated using the Seattle Heart Failure Model, and its agreement level with patient self-expectations of 2-year survival were assessed. A total of 113 patients completed the survey (male 65.5%, median age 75.0 years, interquartile range 66.0–81.0 years). Compared with the Seattle Heart Failure Model prediction, patient expectation of 2-year survival was matched only in 27.8% of patients; their agreement level was low (weighted kappa = 0.11). Notably, 50.9% wished to know “more,” although 27.7% felt that they did not have an adequate prognostic discussion. Compared with the known prognostic variables (eg, age and HF severity), logistic regression analysis demonstrated that female and less depressive patients were associated with patients’ preference for “more” prognostic discussion. Conclusions: Patients’ overall prognostic understanding was suboptimal. The communication process requires further improvement for patients to accurately understand their HF prognosis and be involved in making a better informed decision.
KW - Heart failure
KW - Seattle Heart Failure Model
KW - advance care planning
KW - patient preference
KW - prognosis
UR - http://www.scopus.com/inward/record.url?scp=85097778866&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85097778866&partnerID=8YFLogxK
U2 - 10.1016/j.cardfail.2020.10.009
DO - 10.1016/j.cardfail.2020.10.009
M3 - Article
C2 - 33171293
AN - SCOPUS:85097778866
SN - 1071-9164
VL - 27
SP - 318
EP - 326
JO - Journal of Cardiac Failure
JF - Journal of Cardiac Failure
IS - 3
ER -